Announcements Trials
Browse Landscape

Phase

Phase 3 15Phase NA 10Phase 4 7Phase 2 4Phase 2/3 1Phase 1/2 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 870Carcinoma, Non-Small-Cell Lung 637Prostatic Neoplasms 516Multiple Myeloma 443Neoplasms 425Leukemia, Myeloid, Acute 380Lymphoma 357Melanoma 335Leukemia 335Neoplasm Metastasis 322Lung Neoplasms 308Lymphoma, Non-Hodgkin 303Leukemia, Lymphocytic, Chronic, B-Cell 301Colorectal Neoplasms 282Ovarian Neoplasms 266Pancreatic Neoplasms 249Precursor Cell Lymphoblastic Leukemia-Lymphoma 241Recurrence 240Myelodysplastic Syndromes 233Glioblastoma 212Hodgkin Disease 201Lymphoma, Large B-Cell, Diffuse 197Lymphoma, Follicular 195Brain Neoplasms 195Carcinoma, Renal Cell 190Head and Neck Neoplasms 188Squamous Cell Carcinoma of Head and Neck 186Lymphoma, Mantle-Cell 171Sarcoma 158Fallopian Tube Neoplasms 139

Interventions

incobotulinumtoxinA 1Lenalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Has results × Cancer Pain × Clear all
NCT05328973 2024-12-02

Intraoperative Aromatherapy Versus Placebo for Port-a-Cath Placement Under Monitored Anesthesia Care. A Randomized Controlled Trial

M.D. Anderson Cancer Center

Phase 2 Completed
70 enrolled 18 charts

Cancer Pain

NCT00830180 2021-04-05

Open Label Extension In Cancer Patients

Pfizer

Phase 2 Completed
41 enrolled 15 charts

Cancer Pain, Neoplasms

NCT01931865 2015-12-31

IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

Yale University

Phase 2 Terminated
12 enrolled 6 charts

Cancer Pain, Pain

NCT00684242 2013-01-28

Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 5 charts

Cancer Pain, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡